Trial Profile
dose-finding study of miriplatin arterial injection therapy for advanced hepatocellular carcinoma
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 03 Mar 2015
Price :
$35
*
At a glance
- Drugs Miriplatin (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 26 Feb 2015 Status changed from not yet recruiting to discontinued as reported by University Hospital Medical Information Network - Japan.
- 03 Sep 2014 New trial record